Esperion Therapeutics
ESPR
#6713
Rank
NZ$0.84 B
Marketcap
$4.30
Share price
2.02%
Change (1 day)
109.09%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: NZ$0.84 Billion

As of November 2024 Esperion Therapeutics has a market cap of NZ$0.84 Billion. This makes Esperion Therapeutics the world's 6713th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$0.84 B57.59%
2023NZ$0.53 B-25.64%
2022NZ$0.72 B62.19%
2021NZ$0.44 B-52.26%
2020NZ$0.93 B-61.64%
2019NZ$2.43 B32.35%
2018NZ$1.83 B-24.26%
2017NZ$2.42 B495.78%
2016NZ$0.40 B-44.34%
2015NZ$0.73 B-30.25%
2014NZ$1.04 B309.35%
2013NZ$0.25 B

End of Day market cap according to different sources

On Nov 24th, 2024 the market cap of Esperion Therapeutics was reported to be:

NZ$0.84 Billion
by Nasdaq info icon info icon
NZ$0.84 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$7.44 B 778.57%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$20.89 B 2,366.50%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$248.03 B 29,174.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$138.38 B 16,233.17%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.92 B 481.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.53 B-37.14%๐Ÿ‡บ๐Ÿ‡ธ USA